1. Home
  2. GDV vs TMDX Comparison

GDV vs TMDX Comparison

Compare GDV & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Dividend & Income Trust of Beneficial Interest

GDV

Gabelli Dividend & Income Trust of Beneficial Interest

HOLD

Current Price

$28.96

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$86.30

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDV
TMDX
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
GDV
TMDX
Price
$28.96
$86.30
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$148.22
AVG Volume (30 Days)
97.4K
623.7K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
5.81%
N/A
EPS Growth
N/A
382.18
EPS
N/A
0.61
Revenue
N/A
$605,494,000.00
Revenue This Year
N/A
$24.25
Revenue Next Year
N/A
$18.75
P/E Ratio
N/A
$142.07
Revenue Growth
N/A
37.13
52 Week Low
$26.14
$60.11
52 Week High
$31.00
$156.00

Technical Indicators

Market Signals
Indicator
GDV
TMDX
Relative Strength Index (RSI) 30.52 51.89
Support Level $28.67 $80.29
Resistance Level $29.51 $95.18
Average True Range (ATR) 0.41 4.40
MACD -0.12 -0.41
Stochastic Oscillator 13.98 70.10

Price Performance

Historical Comparison
GDV
TMDX

About GDV Gabelli Dividend & Income Trust of Beneficial Interest

Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, including Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services, and others.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: